Stock analysis, price data, and AI-powered insights for Biogen (BIIB).
Biogen operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for BIIB.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). BIIB Stock Intelligence Report. [stoxpulse.com/stocks/biib]
Disclaimer: The information on this page about Biogen (BIIB) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Biogen.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 26%
Mar 31
HAWKINS bought 2K shares
5d ago
SHERWIN bought 2K shares
5d ago
What Makes Denali Therapeutics (DNLI) One of the B...
3d ago
Congresswoman Who Bought No Stocks In 2025 Is Back...
4d ago
StoxPulse AI results for BIIB: Pulse Score 54/100. Primary sentiment trends from 9 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$29.53B
P/E Ratio
20.0
EPS
$-0.33
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Jun 25
+38.9%
Sep 25
+21.5%
Dec 25
+20.9%
Mar 26
+26.3%
Beat estimates 4 of 4 quarters (100%)
Sector
Healthcare
Industry
Biotechnology
What Makes Denali Therapeutics (DNLI) One of the Best AI Driven Biotech Names
Congresswoman Who Bought No Stocks In 2025 Is Back With More 2026 Trades: Here's The Shopping List
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Find Risky
How Is Biogen’s Stock Performance Compared to Other Biotech Stocks?
EVERSANA Strengthens Commitment to Driving Market Access Growth with Addition of Industry Expert Jen Norton
This House of Representative Just Bought Up To $375K In Biogen Stock
Biogen's Base Is Declining — But 8 Pipeline Readouts Could Flip The Story
This Biogen Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday